Sale!

EIF2AK3 Gene Wolcott-Rallison Syndrome NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The EIF2AK3 Gene Wolcott-Rallison Syndrome NGS Genetic DNA Test is a comprehensive diagnostic tool that identifies mutations in the EIF2AK3 gene, which causes Wolcott-Rallison syndrome – a rare autosomal recessive disorder characterized by early-onset diabetes and skeletal abnormalities. This advanced next-generation sequencing test provides precise detection of genetic variants associated with this serious condition. The test is particularly important for infants and young children presenting with diabetes before six months of age, helping to establish an accurate diagnosis and guide appropriate treatment strategies. Early identification through this $500 USD test enables proactive management of diabetes and skeletal complications, potentially improving long-term outcomes. The test requires a simple blood sample or extracted DNA and provides results within 3-4 weeks, offering families crucial genetic information for informed healthcare decisions.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

EIF2AK3 Gene Wolcott-Rallison Syndrome NGS Genetic DNA Test

Comprehensive Genetic Testing for Rare Diabetes Disorder

The EIF2AK3 Gene Wolcott-Rallison Syndrome NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying one of the rarest forms of neonatal diabetes. Wolcott-Rallison syndrome is an autosomal recessive disorder caused by mutations in the EIF2AK3 gene, which plays a critical role in cellular stress response and protein synthesis regulation. This comprehensive genetic analysis provides families and healthcare providers with definitive answers about this serious condition that affects multiple body systems.

What This Advanced Genetic Test Detects

Our NGS-based genetic test specifically targets and sequences the entire EIF2AK3 gene to identify pathogenic variants responsible for Wolcott-Rallison syndrome. The test examines:

  • Point mutations, insertions, and deletions in the EIF2AK3 gene
  • Autosomal recessive inheritance patterns
  • Genetic variants affecting pancreatic beta-cell function
  • Mutations impacting skeletal development and growth
  • Variants associated with hepatic dysfunction and epiphyseal dysplasia

Who Should Consider This Genetic Test

This specialized genetic test is recommended for individuals presenting with specific clinical features, particularly:

  • Infants and children with diabetes onset before six months of age
  • Patients with persistent neonatal diabetes unresponsive to typical treatments
  • Individuals with skeletal abnormalities including epiphyseal dysplasia
  • Children showing growth retardation and developmental delays
  • Patients with recurrent hepatic dysfunction or liver failure
  • Families with history of consanguinity and similar clinical presentations
  • Siblings of diagnosed individuals for carrier status determination

Key Benefits of Early Genetic Detection

Early identification through genetic testing provides numerous advantages for patients and families:

  • Accurate Diagnosis: Confirms Wolcott-Rallison syndrome versus other neonatal diabetes types
  • Personalized Treatment: Enables targeted diabetes management strategies
  • Proactive Monitoring: Facilitates early intervention for skeletal and hepatic complications
  • Genetic Counseling: Provides families with recurrence risk information
  • Reproductive Planning: Assists in family planning decisions for carriers
  • Improved Outcomes: Early intervention can significantly impact quality of life

Understanding Your Test Results

Our comprehensive genetic report provides clear, actionable information:

  • Positive Result: Identifies pathogenic variants confirming Wolcott-Rallison syndrome diagnosis
  • Negative Result: No EIF2AK3 mutations detected, suggesting alternative diagnoses
  • Variant of Uncertain Significance: Identifies genetic changes requiring further clinical correlation
  • Carrier Status: Identifies individuals with single mutation copies

All results include detailed interpretation by our certified genetic counselors, who provide guidance on next steps and management recommendations.

Test Pricing and Availability

Test Component Price (USD)
Discount Price $500
Regular Price $700
Turnaround Time 3-4 Weeks
Sample Type Blood, Extracted DNA, or Blood on FTA Card

Nationwide Testing Availability

We provide comprehensive genetic testing services across the United States with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified collection centers ensures accessible testing for families nationwide.

Take Control of Your Genetic Health Today

Don’t wait to get answers about potential genetic conditions affecting your family. Our EIF2AK3 Gene Wolcott-Rallison Syndrome NGS Genetic DNA Test provides the clarity needed for informed healthcare decisions. Early detection through advanced genetic testing can make a significant difference in managing this complex condition.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your test. Our genetic specialists are ready to guide you through the testing process and help you understand your results.

Take the first step toward genetic clarity and personalized healthcare management. Contact us now to begin your journey to better health outcomes through advanced genetic testing.